Company Profile
CEO
Mr. Jacob Thaysen Ph.D.(CEO, Interim Chief Commercial Officer & Director)
Sector
Healthcare
Industry
Diagnostics & Research
Employees
8.6K
Beta
1.49
Forward P/E
27.4
52W High
$172.49
52W Low
$81.76
Profit Margin
19.4%
Operating Margin
18.3%
Return on Equity
33.8%
Revenue Growth
4.8%
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and li...
Valuation
Market Cap$23.91B
P/E (TTM)28.73
P/S (TTM)5.48
EV/EBITDA22.68
Cash Flow
FCF Yield+4.2%
SBC Adj. FCF Yield+3.2%
SBC Impact23.9%
Margins & Growth
Profit Margin12.3%
Operating Margin19.2%
Revenue YoY4.8%
Earnings YoY2.3%
Balance
Cash$1.09B
Debt$1.49B
Net Cash$-401.00M
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--